Related Experiment Video
Updated: Jun 5, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Evidence-based chronic heart-failure management programmes: reality or myth?
A Driscoll1, L Worrall-Carter, D L Hare
1Preventative Cardiology, Baker Heart Research Institute, 75 Commercial Road, Melbourne, Victoria, 3004, Australia.
Insights
Chronic heart-failure management programmes (CHF-MPs) are widespread but often fail to follow clinical guidelines. This inconsistency may impact patient outcomes and highlights a gap in evidence-based care for heart failure patients.
Area of Science:
- Cardiology
- Health Services Research
Background:
- Chronic heart-failure management programmes (CHF-MPs) are standard care for heart failure (HF) patients.
- Implementation of CHF-MPs aims to optimize patient outcomes.
Purpose of the Study:
- To assess adherence of CHF-MPs to evidence-based clinical guidelines.
- To evaluate the optimization of patient outcomes within these programs.
Main Methods:
- A prospective, cross-sectional national audit was conducted.
- Data collected from 55 CHF-MPs across Australia, including patient characteristics and interventions.
- 1157 patients from 48 programs were analyzed.
Main Results:
- CHF-MPs are unevenly distributed, with only 6.3% of hospitals offering them.
- Only 20% of the potential national caseload (8000 patients) was managed by CHF-MPs.
- Significant heterogeneity in care models and medication titration by nurses was observed (e.g., <50% allowed medication titration).
- 16% of patients had NYHA Class I without echocardiography confirmation of HF.
Conclusions:
- CHF-MPs are rapidly expanding in Australia.
- Many programs do not align with expert clinical guidelines for CHF management.
- This poor translation of evidence into practice raises concerns about the quality and consistency of patient health outcomes.
Background:
Chronic heart-failure management programmes (CHF-MPs) have become part of standard care for patients with chronic heart failure (CHF).
Objective:
To investigate whether programmes had applied evidence-based expert clinical guidelines to optimise patient outcomes.
Design:
A prospective cross-sectional survey was used to conduct a national audit.
Setting:
Community setting of CHF-MPs for patients postdischarge.
Sample:
All CHF-MPs operating during 2005-2006 (n=55). Also 10-50 consecutive patients from 48 programmes were recruited (n=1157).
Main Outcome Measures:
(1) Characteristics and interventions used within each CHF-MP; and (2) characteristics of patients enrolled into these programmes.
Results:
Overall, there was a disproportionate distribution of CHF-MPs across Australia. Only 6.3% of hospitals nationally provided a CHF-MP. A total of 8000 postdischarge CHF patients (median: 126; IQR: 26-260) were managed via CHF-MPs, representing only 20% of the potential national case load. Significantly, 16% of the caseload comprised patients in functional New York Heart Association Class I with no evidence of these patients having had previous echocardiography to confirm a diagnosis of CHF. Heterogeneity of CHF-MPs in applied models of care was evident, with 70% of CHF-MPs offering a hybrid model (a combination of heart-failure outpatient clinics and home visits), 20% conducting home visits and 16% conducting an extended rehabilitation model of care. Less than half (44%) allowed heart-failure nurses to titrate medications. The main medications that were titrated in these programmes were diuretics (n=23, 96%), β-blockers (n=17, 71%), ACE inhibitors (ACEIs) (n=14, 58%) and spironolactone (n=9, 38%).
Conclusion:
CHF-MPs are being implemented rapidly throughout Australia. However, many of these programmes do not adhere to expert clinical guidelines for the management of patients with CHF. This poor translation of evidence into practice highlights the inconsistency and questions the quality of health-related outcomes for these patients.
Related Concept Videos
Heart Failure V: Medical Management
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy VI: Nursing Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies